{"id":"comparator-loratadine","safety":{"commonSideEffects":[{"rate":"12","effect":"Headache"},{"rate":"8","effect":"Somnolence"},{"rate":"4","effect":"Fatigue"},{"rate":"3","effect":"Dry mouth"}]},"_chembl":{"chemblId":"CHEMBL998","moleculeType":"Small molecule","molecularWeight":"382.89"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Loratadine competitively binds to peripheral H1 histamine receptors, preventing histamine from triggering allergic symptoms such as itching, sneezing, and urticaria. Its lipophilic structure and large molecular size limit blood-brain barrier penetration, resulting in minimal sedation compared to first-generation antihistamines. It is a non-sedating second-generation antihistamine used for symptomatic relief of allergic conditions.","oneSentence":"Loratadine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses without significant central nervous system penetration.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:03.342Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"},{"name":"Chronic urticaria"}]},"trialDetails":[{"nctId":"NCT01055756","phase":"PHASE3","title":"Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis","status":"WITHDRAWN","sponsor":"Azidus Brasil","startDate":"2010-01","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT00979901","phase":"PHASE3","title":"Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-03","conditions":"Seasonal Allergic Rhinitis","enrollment":1577},{"nctId":"NCT00963599","phase":"PHASE3","title":"Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1999-09","conditions":"Seasonal Allergic Rhinitis","enrollment":907},{"nctId":"NCT00960141","phase":"PHASE3","title":"A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-08","conditions":"Seasonal Allergic Rhinitis","enrollment":829},{"nctId":"NCT00972738","phase":"PHASE3","title":"Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-04","conditions":"Seasonal Allergic Rhinitis","enrollment":1214},{"nctId":"NCT00963469","phase":"PHASE3","title":"Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1079},{"nctId":"NCT01390441","phase":"PHASE1","title":"A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-07","conditions":"Rheumatoid Arthritis","enrollment":100},{"nctId":"NCT01228630","phase":"PHASE3","title":"Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.","status":"COMPLETED","sponsor":"Azidus Brasil","startDate":"2011-08","conditions":"Perennial Allergic Rhinitis","enrollment":156}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":581,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Comparator: loratadine","genericName":"Comparator: loratadine","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Loratadine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses without significant central nervous system penetration. Used for Allergic rhinitis (seasonal and perennial), Chronic urticaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}